Abstract
Recently, the expectation for percutaneous ablation has been increasing in the treatment of renal cell carcinoma (RCC). Potential advantages of this technique are good local control ability with a minimally invasive approach. Moreover, preservation of renal function is also excellent even in patients with reduced renal function. Some recent studies suggest that percutaneous ablation provides comparable oncologic outcomes to nephrectomy with little loss of renal function. This article provides an over view of percutaneous ablation therapy by focusing on radiofrequency ablation (RFA), and discusses the role of this promising technology in the treatment of RCC.
